“…However, it remains unclear to what extent basal differences in testosterone could have influenced the findings of the present study given the controversy reported in the literature in both lowlanders (Friedl et al.,
1988; Vasankari et al.,
1993) and native highlanders (Garmendia et al.,
1982; Gonzales et al.,
2009) exposed to HA. Furthermore, we were unable to (more) directly assess BBB integrity by employing dynamic contrast‐enhanced and dynamic susceptibility contrast MRI (Tofts & Kermode,
1991) or via quantification of CSF to blood NVU proteins and/or transcerebral exchange (arterial‐to‐jugular venous concentration) gradients (Bailey, Bain et al.,
2022; Lindblad et al.,
2020), hence the focus on ‘surrogate’ albeit validated peripheral biomarkers (Janigro et al.,
2020). Finally, it would have been of interest to assess cerebral tissue O 2 consumption/metabolism using near infra‐red spectroscopy and/or derivation of cerebral mitochondrial
inferred from arterial and jugular venous blood gas data, given prior research documenting that local reductions in (mitochondrial)
may serve as the upstream (potentially hormetic) signal underlying systemic/cerebral free radical formation (Bailey et al.,
2011; Bailey et al.,
2018; Bailey et al.,
2009; Woodside et al.,
2014).…”